Artificial Intelligence in breast cancer screening – part 3: implications for the UK
In the third of our posts regarding the recent major international evaluation of AI in breast cancer screening, we consider what might be the implications […]
Articles by Peter Sasieni
Artificial Intelligence in breast cancer screening – part 2: international differences
Previously we reported on a major study evaluating AI as a tool to identify breast cancer on mammography. The results were impressive. In the UK, […]
Artificial Intelligence in breast cancer screening – part 1: are computers developing 20/20 vision?
Despite many technological advances in mammographic imaging over the last century, breast cancer screening is largely the same as it was when first studied 60 […]
The Mysterious Case of an American Epidemic of Vaping-Related Lung Injuries
Deep down every epidemiologist imagines themselves as Sherlock Holmes: equipped with little more than a magnifying glass and a good brain, they dream of becoming […]
Which screening guidelines are woefully inadequate?
Following a high-profile article calling for a change in guidelines to make it easier for African Americans to be eligible for lung cancer screening, Prof […]
Isolines and Rabbit Holes: Adventures in ROC Space
There is an apocryphal story about Queen Victoria. Having enjoyed Alice’s Adventures in Wonderland, the queen requested a copy of Lewis Carroll’s next book. Carroll, […]
Equality and Equity in Cancer Screening: How can we personalise interventions and still be fair?
The classic American illustration explaining the difference between equity and equality is of three people trying to watch a baseball game from behind a fence. […]
Survivor bias and cervical cancer audit: all is not what it seems
In todays post we discover how lessons learnt during World War two can be applied to cervical cancer audit. The Curious Case of the Missing […]
Why don’t women receive invitations to cervical screening after they turn 65?
Women around the world attend cervical screening regularly during most of their adult life, but in most countries, they are not encouraged to continue once […]
Screening iconoclasm series: Is it time for cancer screening to become non-binary?
In our final iconoclasm series post, Peter Sasieni explores the merits of making cancer screening non-binary. The classic paradigm for diagnostic testing and medical screening […]
Screening iconoclasm series: Could you be more specific about what you mean by specificity?
In this post, Peter Sasieni argues that it is time to be more specific about our definitions of specificity and false positive tests. How will […]